Spondyloarthritis & psoriatic arthritis
Determinants associated with the prescription of a first biologic therapy in patients with axial spondyloarthritis and concomitant fibromyalgia in daily practice
Authors' conclusion
The determinants associated with the decision of rheumatologists to prescribe a first bDMARD in patients with SpA/FM were mostly objective, in line with the recommendations in the literature.
Study context
- Population
- Rheumatologists practising in Normandy, France; decision to prescribe a first bDMARD in patients with spondyloarthritis (SpA) and concomitant fibromyalgia (FM)rheumatologists responding
- Participants
- 54/113 rheumatologists
- Outcome
- Determinants associated with rheumatologists' decision to prescribe a first bDMARD in patients with SpA/FM
Methodological detailssurvey-based, mixed (qualitative and quantitative) method, web-based questionnaire
- Survey-based
- Mixed (qualitative and quantitative) method
- Web-based questionnaire
Main finding
As reported in the abstract
Criteria contributing to the decision to prescribe a first bDMARD
- Four criteria considered by all respondents to contribute: arthritis on physical examination, extra-articular manifestations, systemic inflammation and structural damage on imaging
Observational data: associations, not effects.
Original publication
Determinants associated with the prescription of a first biologic therapy in patients with axial spondyloarthritis and concomitant fibromyalgia in daily practice. Joint Bone Spine. Published 11 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →